latest news releases from the newsroom
TG Therapeutics, Inc.
Manhattan Pharmaceuticals Announces Completion of Enrollment in Phase 2a Study of Topical PTH (1-34) for Psoriasis
NEW YORK, April 10, 2008 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) announced today that it has completed patient enrollment in its ongoing Phase 2a clinical study of Topical PTH (1-34). This randomized, double-blind, vehicle-controlled, parallel group study is designed to evaluate safety and preliminary efficacy of Topical PTH (1-34) for the treatment of psoriasis. The study randomized 61 patients into three treatment groups (two dose levels of Topical PTH (1-34) and one vehicle only group) for an 8-week treatment period at four U.S. clinical trial sites. The vehicle used in this study is the topical product without the active ingredient, PTH (1-34). The company expects to announce the results of this study in summer 2008.
HickoryTech Provides Details for First Quarter 2008 Earnings Release and Conference Call
MANKATO, Minn., April 10, 2008 (PRIME NEWSWIRE) -- HickoryTech Corporation (Nasdaq:HTCO), an integrated communications solution provider headquartered in Mankato, Minn., will release its first quarter 2008 results on Wednesday, April 30 after the market closes. The Company will discuss its results in a conference call on Thursday, May 1 at 9 a.m. CT.
SOYO Group Inc.
SOYO to Feature Honeywell Consumer Electronics Products At Spring Retail Vision
ONTARIO, Calif., April 10, 2008 (PRIME NEWSWIRE) -- SOYO Inc. (OTCBB:SOYO) today announced that it will attend Retail Vision in Orlando, Florida. The show will take place from April 14, 2008 to April 16, 2008 at The Hyatt Regency Grand Cypress. SOYO's exhibit will feature the Honeywell brand of consumer electronics products, part of SOYO's continuing roll out of the Honeywell product line.